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Assaying Potential Carcinogens with
DrosophiIat
byF. H. Sobeist and E. Vogelt
Drosophila offers many advantages for the detection of mutagenic activity of carcinogenic
agents. It provides the quickest assay system for detecting mutations in animals today. Its genera-
tion time is short, and Drosophila is cheap and easy to breed inlargenumbers. The simple genetic
testingmethods give unequivocal answers about thewhole spectrum ofrelevant genetic damage. A
comparison ofthedetection capacity ofassays sampling different kinds ofgenetic damage reveal-
ed that various substances are highly effective in inducing mutations but do not produce
chromosome breakageeffects atall, oronly at muchhigherconcentrations than those required for
mutation induction. Of the different assay systems available, the classical sex-linked recessive
lethal test deserves priority, in view of its superior capacity to detect mutagens. Of practical im-
portance is also its high sensitivity, because a large number of loci in one fifth of the genome is
tested fornewly induced forward mutations, includingsmall deletions.
The recent findings that Drosophila is capable of carrying out the same metabolic activation
reactions as the mammalian liver makes the organism eminently suitable for verifying results ob-
tained in prescreening with fast microbial assay systems. An additional advantage in this respect
is the capacity of Drosophila for detecting short-lived activation products, because intracellular
metabolic activation appears to occurwithin the spermatids and spermatocytes.
Introduction
Recent results with microbial assay systems,
such as the Ames test with Salmonella, have
demonstrated a striking overlap between car-
cinogenicity and mutagenicity. That is, the great
majority of compounds capable of producing
malignant transformation are also effective in
producing genetic changes in the form of
heritable mutations. The possibilities the Ames
test has to offer for a quick identification of
potential carcinogens in the human environment
is indeed a major accomplishment. Regulatory
measures, with all the consequences for society,
should, in our opinion, not be based on data ob-
tained with a single assay system, but would re-
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quire the confirmation after the application of a
battery of different test systems. Since man is
more closely related to other mammals than bac-
teria, various authors (1,2) emphasize the im-
portance of mammalian assay systems. From a
toxicological point ofview, the intact mammal ob-
viously offers enormous advantages over many
other assay systems, since information regarding
pharmacokinetics, as resorption, elimination, and
drug metabolism both inside and outside the
target cells, can only be obtained by studies on
mammals. With regard to the genetic data that
can be obtained from the intact mammal, we tend
tobe more pessimistic, however.
From the point of view of genetic hazards,
transmissible point mutations and smalldeletions
deserve probably the highest priority (3), par-
ticularly so since the induction of these changes
correlates with the risk ofcarcinogenesis. Forthe
detection of this class of genetic damage one has
until now to rely entirely on specific locus tests.
In view of the extreme costs and labor involved,
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where these can be carried out. The time and cost
required to collect meaningful data places severe
limitations on the number of chemicals and con-
centrations that can be investigated. Experimen-
tation is restricted to high concentrations, and
since dose-effect curves with chemical mutagens
do not exhibit simple proportionality, there is no
a p7iori justification for linear extrapolation to
low concentrations.
All other in vivo mammalian assay systems
which can be employed for routine screening pur-
poses rely on the detection of chromosome
breakage effects, whether these are recovered
from bone marrow, peripheral blood, testes, or in
dominant lethal assays. Recent experiments with
Drosophila have revealed that a number of sub-
stances, the indirectly-acting carcinogens in par-
ticular, are highly effective in inducing mutations
but do not produce chromosome breakage effects
at all or induce breakage effects only at much
higher concentrations than those required for
mutation induction. Such compounds thus could
spuriously register as safe in any routine mam-
malian in vivo assay system. Since it is par-
ticularly these substances which entail the risk of
producing malignancy, mammalian tests relying
on chromosome breakage cannot be considered as
diagnostic. Salmonella, yeast, and mammalian
cell cultures with microsomal extracts or Droso-
phila would seem preferable.
Advantagesof Drosophila as aTest System
In the light of these considerations, the
possibilities afforded by Drosophila for detecting
various classes of mutagens will be discussed
(4-6). In contrast to most other assay systems,
where only one class of genetic damage can be
studied, special tester strains permit the
simultaneous assessment of the total spectrum of
genetic changes, ranging from recessive lethal or
visible mutations, small deletions, translocations,
chromosome loss, and dominant lethals to nondis-
junction and genetic recombination. This pro-
vides opportunity for a quantitative comparison
of the detection capacity for various genetic end
points. Before proceeding to a more detailed
discussion of this topic, we want to elaborate on
the capacity ofmetabolic activation, which makes
Drosophila particularly suitable for the verifica-
tion of the results with indirect carcinogens, as
obtained in microbial assay systems.
MetabolicActivation by Insect Microsomes
Indirect mutagens and carcinogens require ac-
tivation by the microsomal enzyme systems pre-
sent in the mammalian liver. In microbial test
systems, mutagens of this kind register as
negative, unless host-mediated assays or plating
on microsomal extracts from mammalian tissues
are employed. Recent discoveries indicate that
insect microsomes are capable of facilitating the
same enzymic reactions as those from the mam-
malian liver. The endoplasmic reticulum is con-
sidered the center for drug and pesticide
metabolism, and the enzymes involved are
mixed-function oxidases. Unlike the mammalian
liver, insects do not have any specific organ in
which those enzymes are predominantly located.
Biochemical characterization of the microsomal
enzymes in insects has demonstrated that
numerous foreign compounds are oxidatively
metabolized by isolated microsomes or other
subcellular fractions. The nature and diversity of
the reactions catalyzed indicate that insect
microsomes exhibit a similar degree of metabolic
versatility and substrate nonspecificity as those
from mammalian liver (7). Among the various
types of reactions catalyzed are, for example, ox-
idative attack of aromatic rings, C-alkyl, N-alkyl,
S-alkyl, or O-alkyl groups, all fundamental steps
that are well known to play a part in the bioac-
tivation of indirect carcinogens and mutagens.
Most of the more direct biochemical information
is derived from studies with the housefly, Musca
domestica. The evidence that Drosophila is
capable of facilitating similar reactions is based
on mutation studies carried out mainly by Vogel
duringthe last few years (6).
Some forty compounds that require metabolic
activation have now been tested in Drosophila
and yielded positive response for the induction of
recessive lethals (see Table 1). First demonstra-
tion of biotransformation was obtained by Clark
(8) for the pyrrolizidine alkaloid, heliotrine, and
by Pasternak (9-11) for the dimethyl and
diethylnitrosamines. More recently, Vogel has
studied the response of Drosophila for various
groups of indirectly-acting carcinogens. His data,
and those of earlier studies, show that some 40
compounds falling into nine different groups, pro-
duce a positive response in tests for recessive
lethal mutations with Drosophila (6). The genetic
activity of these widely different substances con-
vincingly demonstrate the versatility and lack of
substrate specificity of the Drosophila enzyme
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to indirect carcinogens.
Chemical No. Mutagenic
class tested activity
Triazenes 12 +
Nitrosamines 6 +
Hydrazo-, azoxyalkanes 3 +
Oxazaphosphorines 3 +
DDT, DDA 2 +
Hempa 1 +
Aflatoxins 1 +
Pyrrolizidine Alkaloids 11 +
Vinyl chloride, chloroprene
andrelated compounds 4 +
4-Dimethylamino-trans-stilbene 1 +
4-NitroquinolineN-oxide 1 +
45
systems. Other convincing proof for the capacity
of mammlian-like metabolic activation of Dro-
sophila is provided by the finding of Pasternak
(10) that out of six nitrosamines tested, only
N-nitrosoethly-tert-butylamine was non-
mutagenic. This substance was likewise noncar-
cinogenic in rats (12)and nonmutagenic in E. coli
with or without rat liver microsomes (13).
StageSpecificityof Indirect Mutagens
One of the characteristic features of chemical
mutagens is their specificity of action. Failure to
detect mutagenic activity may result from pro-
nounced stage-specific response. An additional
advantage Drosophila has to offer is the facility
with which mutagenic activity can be sampled in
a wide variety of different germ cell stages. In
fact, one ofthe classical examples ofspecificity at
the cellular level is provided by Auerbach's ob-
servations (14) for formaldehyde. Sensitivity
differences between germcells canbe ascertained
by mating the treated males to fresh females in a
succession of different broods, or in females by
setting up successive subcultures.
In the studies on the mode of action of indirect
mutagens by Vogel, the application ofthis brood-
ing technique has revealed the interesting obser-
vations that indirectly acting carcinogens exhibit
a similar stage-specific sensitivity pattern, de-
spite considerable differences in their mode of
activation (see Fig. 1). That is, spermatids and
spermatocytes appear to show greatest response
(6,15,16). Thus representatives of four different
groups of indirect mutagens, that is, PDMT
(1-phenyl-3, 3-dimethyltriazene) 2,4,6-TCl-PDMT,
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FIGURE 1. Stage-specific induction of recessive lethals by
various indirectly acting mutagens in Drosophilamales after
feeding for 24 hr: (0) 2,4,6-TCl-PDMT; (e) PDMT (phenyl
dimethyltriazene); (A) azoxymethane; (0) DEN; (A)
cyclophosphamide.
diethyl nitrosamine, azoxymethane, and cyclo-
phosphamide all exhibit peak activity 4-6 days
after treatment and reduced fertility after 7-9
days. From studies with the electron microscope
by Tates (17), it is known that in these stages
the endoplasmic reticulum is most highly de-
veloped. Since this system is regarded as the
site of metabolic activation, these observa-
tions provide an indication for intracellular ac-
tivation within these particular stages of sperm
development. Thus, even in situations where
short-lived activation products are involved, with
mutagenic effects restricted to the cells in which
activation had occurred, Drosophila will still per-
mit their detection. Such effects may well be
missed in host-mediated or in vitro micro-
some-facilitated assay systems; the experiences
with the nitrosamines in other test systems seem
topresent an example in case.
Comparison of Endpoints and Validation of
Assay Systems
A crucial point in the analysis of potential
mutagens by use of Drosophila is the selection of
the most suitable assay system for the detection
of genetic effects. Drosophila permits the
simultaneous assessment ofthe total spectrum of
genetic effects. As part ofa screening program in
a whole battery of different test systems, it will
not be possible to assay in Drosophila for all
genetic changes that might be analyzed. Obvious-
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various techniques andtester strains available.
The relevant criteria applied require that the
tests employed should possibly be nonspecific and
capable of detecting a wide range of mutagens,
and that they permit the detection of genetic
damage relevant to man. In brief, what we need
to know is what test system will be most reliable
in detecting potential mutagens. Pertinent ques-
tions thus are the extent to which induction of
one type of genetic change correlates with the oc-
currence of another, and the incidence for a given
mutagen, at different concentrations, of different
kinds of genetic changes. To this end Vogel et al.
(16,18) carried out a comparative study after
feeding different mutagens to males, determining
the frequency of induction at various concentra-
tion levels of recessive lethals, dominant lethals,
and chromosome loss (and in some instances
translocations).
For the presentation of the results of these ex-
periments, in summarized form, a comparison for
the different genetical end points is given in
terms of the ratio between the lowest effective
concentration (LEC) and LD5o. LEC is defined as
the lowest concentration of a chemical which
causes a significant increase of the mutation or
breakage frequency above that in the controls
(18). This estimate provides evidence ofthe abili-
ty of a mutagen to induce various kinds of
genetical damage at toxic, subtoxic, and very low
dose levels. It is this kind of information which is
obviously needed for the evaluation of assay
systems.
From a comparison ofthe results obtained with
MMS (methyl methanesulfonate), TEB (tetra-
ethyleneiminobenzoquinone), 2,4,6-TCl-PDMT
and DEN (diethylnitrosamine) it became clear that
dominant lethals and chromosome loss cannot be
detected at low concentrations, except when the
polyfunctional agent TEB is used (see Table 2),
MMS, for example, gives a LEC:LD50 ratio for
recessive lethals of 1:100, but 10-fold or even 20-
fold higher concentrations are required for induc-
ing significant numbers of dominant lethals and
chromosome loss, respectively. For the triazene,
1/1000 of LD50 is sufficient for recessive lethal in-
duction, but 1:4 and 1:2 are the ratios calculated
for dominant lethals, chromosome loss and trans-
locations. These data clearly demonstrate that
the resolving power for detecting potent muta-
gens with Drosophila depends on the genetic end-
point applied, and this finding is of significance
when evaluating testing procedures. The obser-
vation that lowest LEC values and thus highest
mutagenic effectiveness was recorded for reces-
sive sex-linked lethals, clearly indicates the
superior detection capacity of this simple
classical assay system for the detection of
mutagens. It is of practical importance, that by
using the whole X-chromosome about one fifth,
that is a sizable section ofthe genome, is included
in the test. The large number of loci which are
tested in this way guarantee for the high sen-
sitivity of the recessive lethal test. Compared to
the mouse, this is indeed atremendous advantage
(19). Since, as has been stated above, recessive
lethals do include small deletions, these findings
are of significance in the detection of this most
important class ofgenetic damage.
Another interesting finding in these studies is
that diethyl nitrosamine (5mM) is highly effective
in inducing recessive lethals of up to 25% in the
X-chromosome, in fact mutating more than 100%
of the genome. When considering that detrimen-
tals may be 10-20 times as frequent as recessive
lethals (20), the mutagenic potential of this com-
pound is indeed formidably high. By contrast, at
the same concentration, no chromosome breakage
effects are produced at all. The results, in this re-
spect, are similar to those obtained with diethyl
sulfate (21-26) and hycanthone (27). Mutagens
of this kind would be difficult to detect in any
assay system in which chromosome breakage is
applied as the only criterion of mutagenic activi-
ty. For dominant lethal induction in rats and
mice, DEN and dimethyl sulfate (DMS), related
to diethyl sulfate, were indeed ineffective (28,
29): similarly negative results were recorded for
dimethylnitrosamine (DMN) and N-nitrosomor-
pholine (30), though they are highly effective in
producingmutations in Drosophila.
The observation that mutagens like MMS and
TEB produce only chromosome aberrations at
considerably higher concentrations than those re-
quired for recessive lethal induction is likewise of
interest in assessing the detection capacity of
various assay systems. Findings like these raise
the possibility that, when assay systems relying
on chromosome breakage only, as is, in fact, the
case for all routine mammalian in vivo tests,
whether these be dominant lethals, chromosome
aberrations in bone marrow or peripheral blood,
translocations or micronuclei, false negatives can
be obtained, simply because the concentration at
thetarget cells is notsufficiently high.
An indication of such phenomena has been ob-
tained by Vogel when comparing the mutagenic
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Chromosome loss
Recessive Dominant Partial Translocations
Compound lethals lethals Entire(X,Y) (YLYS) (II-III)
CH3S02 0 CH3 1:00 1:10 1:10 1:5 Notest
(MMS)
0
H2C CH2
H,C
"' \ CH2 1:5000 1:1000 1:200 1:200 1:1000
H2C -1 N N"O H2 ,.4
, N J N I HkC Y CH2
0
(TEB)
Cl - ,CH3 1:1000 1:4 1:2 - 1:4
Cl- yN= N-N
" H
(2,4,6-TCl-PDMT)
HsC2
-N-NO 1:100 - -
HsC2
(DEN)
Table 3. Specific activity ofindirect mutagens (carcinogens) inDrosophila.
Recessive Dominant Chromosome loss Translocations
Chemical lethals lethals Entire (X,Y) Partial (Y) (II-III)
DEN + 0 0 0 0
2,4,6-TCl-PDMT + (+)? (+) 0 (+)
3-PyDMT + 0 Notest Notest No test
Cyclophosphamide + 0 0 0 Notest
Trofosfamide + 0 0 0 Notest
Ifosfamide + 0 0 0 Notest
effectiveness of 1-(pyridyl-3)-3,3-dimethyl-
triazene (3-PyDMT), and three oxazaphos-
phorines, cyclophosphamide, ifosfamide, and
trofosfamide (Table 3). For these substances,
recessive lethal induction is concentration-
independent; that is, the recessive lethal yield
never exceeds 1-3% (31). This observation is con-
sidered as an indication that the amount of active
metabolites at the target is restricted, by a rate-
limiting factor in the metabolism ofthese indirect
mutagens. Chromosome breakage effects are not
observed after the application of these four
mutagens. However, one should bear in mind that
with powerful mutagens like MMS, TEB, and
PDMT, no chromosome loss and dominant lethals
are observed at concentrations yielding recessive
lethal frequencies equivalent to those obtained
for PyDMT and the three oxazaphosphorines.
Substantially higher concentrations were in fact
required to obtain a significant increase. When
considered together, these findings suggest then
that because of the existence of a rate-limiting
factor, or of the extreme toxicity of the com-
pounds in question, a potent chromosome breaker
may remain undetected.
There is another reason, we believe, why in
prescreening for carcinogens the tests for muta-
genicity deserve priority to those relying on
chromosome breakage. And this is that as a pri-
mary effect there does not seem to be a causal
relationship between the carcinogenic potential
and the induction ofchromosome aberrations.
Experimental studies quoted in this paper weresupported in
part by PHS Research Grant No. ESO 1027-02 from the Na-
tional Institute of Environmental Health Sciences (U.S.) and
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